Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SYK | P43405 | 6/20 | 0.48 |
| ▸ | CDC25B | P30305 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | RAD52 | P43351 | 1/20 | 0.46 |
| ▸ | GFER | P55789 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | AURKA | O14965 | 1/20 | 0.42 |
| ▸ | EGFR | P00533 | 1/20 | 0.42 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.42 |
| ▸ | SRC | P12931 | 1/20 | 0.42 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.42 |
| ▸ | PTK6 | Q13882 | 1/20 | 0.42 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18391971 | 0.88 | CDC25B (0.48) | SYKCDC25BMEN1KMT2APOLB | |
| SCHEMBL13223236 | 0.88 | CDC25B (0.48) | SYKCDC25BMEN1KMT2APOLB | |
| SCHEMBL1318687 | 0.84 | SYK (0.63) | SYKMEN1KMT2APOLBRAD52 | |
| SCHEMBL17130325 | 0.82 | IDO1 (0.53) | SYKCDC25BMEN1KMT2APOLB | |
| SCHEMBL12387588 | 0.81 | SYK (0.57) | SYKKMT2ACYP3A4TSHRAURKA | |
| SCHEMBL18391969 | 0.78 | KCNH3 (0.58) | MEN1KMT2ATAAR1 | |
| SCHEMBL25830630 | 0.77 | KCNH3 (0.46) | TAAR1 | |
| SCHEMBL18385065 | 0.77 | KCNH3 (0.46) | TAAR1 | |
| SCHEMBL17130323 | 0.76 | CDC25B (0.45) | SYKCDC25BMEN1KMT2APOLB | |
| SCHEMBL7564159 | 0.76 | SYK (0.64) | SYKMEN1KMT2APOLBRAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9447171-B2 | Purification process for fragment antibodies | FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (GB) | 2016-09-20 | — | — | US | disclosed |
| US-20110190478-A1 | Purification Process for Fragment Antibodies | FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (GB) | 2011-08-04 | — | — | US | disclosed |
| US-20110046353-A1 | Purification Process for Anitbody Fragments Using Derivatized Triazines as Affinity Ligands | FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (GB) | 2011-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110190478-A1 | Purification Process for Fragment Antibodies | NEFM, IGLV6-57, FIBP | SYK 58/4885CDC25B 3332/4885MEN1 2438/4885 |
| US-20110046353-A1 | Purification Process for Anitbody Fragments Using Derivatized Triazines as Affinity Ligands | FCGR3B, FCGR2A, NMBR | SYK 607/4885CDC25B 2184/4885MEN1 2412/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.